Spk-8011: Preliminary Results from a Phase 1/2 Dose Escalation Trial of an Investigational AAV-Mediated Gene Therapy for Hemophilia a

被引:0
|
作者
George, Lindsey A.
Ragni, Margaret V.
Samelson-Jones, Ben J.
Cuker, Adam
Runoski, Alexa R.
Cole, Grace
Wright, Fraser
Chen, Yifeng
Hui, Daniel J.
Wachtel, Katie
Takefman, Daniel
Couto, Linda B.
Reape, Kathleen Z.
Carr, Marcus E.
Anguela, Xavier M.
High, Katherine A.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
604
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Results of a phase 1 open-label, dose escalation study of gene therapy with AAV2-hAQP1 as treatment for radiation-induced xerostomia and parotid gland hypofunction
    Brennan, M.
    Passineau, M.
    Saunders, D.
    Sroussi, H.
    Gaudilliere, D.
    Pfister, D.
    Fernandez, A.
    Liu, J.
    Dubois, N.
    Zeldin, R.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A48 - A48
  • [22] AAV-mediated gene transfer with GALGT2 in Duchenne muscular dystrophy: design of an ongoing phase I/II clinical trial
    Flanigan, K.
    Chicoine, L.
    Cheatham, J.
    Cheatham, S.
    Simmons, T.
    Lowes, L.
    Iammarino, M.
    Miller, N.
    Alfano, L.
    Rinaldi, F.
    Waldrop, M.
    Zygmunt, D.
    Xu, R.
    Martin, P.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S68 - S69
  • [23] Long-Term Results of a Phase 1 Dose Escalation Trial of Ablative Stereotactic Body Radiation Therapy
    Mercier, Carole
    Billiet, Charlotte
    Ost, Piet
    Joye, Ines
    Meijnders, Paul
    Vermeulen, Peter
    Dirix, Luc
    Verellen, Dirk
    Dirix, Piet
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1490 - 1496
  • [24] B-AMAZE, A PHASE 1/2 TRIAL OF A NOVEL INVESTIGATIONAL ADENO ASS OCIATED VIRUS (AAV) GENE THERAPY (FLT180A) IN SUBJECTS WITH SEVERE OR MODERATELY SEVERE HEMOPHILIA B (HB)
    Chowdary, P.
    Tuddenham, T.
    Brooks, G.
    Patel, S.
    Short, G.
    Smith, A.
    Nathwani, A.
    HAEMATOLOGICA, 2019, 104 : 1 - 2
  • [25] Positive Cohort 1 Results from the Phase 1/2 Trial with AAV8-Mediated Liver-Directed Gene Therapy in Adults with Glycogen Storage Disease Type Ia
    Weinstein, David A.
    Ahmad, Ayesha
    Lee, Connie
    Poma, Allen
    Crombez, Eric
    MOLECULAR THERAPY, 2019, 27 (04) : 12 - 12
  • [26] Positive cohort 1 results from the phase 1/2, AAV8-mediated liver-directed gene therapy trial in glycogen storage disease type Ia (GSDIa)
    Derks, T. G.
    Martin-Hernandez, E.
    Ahmad, A.
    Rodriguez-Buritica, D.
    Mitchell, J.
    Lee, C.
    Poma, A.
    Crombez, E.
    Weinstein, D. A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A14 - A14
  • [27] GO-8: Preliminary Results of a Phase I/II Dose Escalation Trial of Gene Therapy for Haemophilia a Using a Novel Human Factor VIII Variant
    Nathwani, Amit C.
    Tuddenham, Edward
    Chowdary, Pratima
    McIntosh, Jenny
    Lee, Doyoung
    Rosales, Cecilia
    Phillips, Mark
    Pie, Jun
    Zhou Junfang
    Meagher, Michael M.
    Reiss, Ulrike
    Davidoff, Andrew M.
    Morton, Chris L.
    Riddell, Anne
    BLOOD, 2018, 132
  • [28] Phase I dose escalation clinical trial of stereotactic body radiation therapy (SBRT) for locoregional recurrences of ovarian cancer: Dose escalation and preliminary outcomes and quality of life results
    Robin, T. P.
    Smith, D. E.
    Diamond, J. R.
    Lefkowits, C.
    Corr, B. R.
    Guntupalli, S. R.
    Behbakht, K.
    Fisher, C. M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 150 - 151
  • [29] Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis: Preliminary Results
    Tifft, C.
    D'souza, P.
    Johnston, J.
    Acosta, M.
    Rothermel, C.
    Thurm, A.
    Karunakara, A.
    Thorp, B.
    Ross, P.
    Jameson, J.
    Vaughn, T.
    Valencia, D.
    De Boever, E.
    Corcoran, G.
    ANNALS OF NEUROLOGY, 2021, 90 : S98 - S98
  • [30] Subretinal Gene Therapy in Patients with Bietti Crystalline Dystrophy: Preliminary Results of a Phase 1/2 Clinical Trial
    Yin, Shiyi
    Zhang, Haihan
    Chen, Jieqiong
    Wang, Jinyuan
    Li, Yang
    Yang, Qiong
    Sha, Ying
    Lv, Hua
    Zhao, Xiaoping
    Guan, Ning
    Chen, Ruixue
    Mao, Hongxia
    Sun, Xiaodong
    Wei, Wenbin
    MOLECULAR THERAPY, 2024, 32 (04) : 81 - 82